QUOTED. March 20, 2018. Raul Nogueira.
Check out what Raul Nogueira, the principal investigator of the DAWN acute stroke clinical trial, had to say about the new paradigm for treating strokes that should result from the study data, which device-maker Stryker is getting out ahead of.
"It's more than opening up the window from six to 24 hours; it's also another way of thinking about stroke. It's more physiology-based rather than time-based." –Raul Nogueira, neuroendovascular division director, Grady Memorial Hospital
- Find out more: Stryker Pushes For Changes To Stroke Care After DAWN
Click here for a free trial of Medtech Insight